Rethinking Risk: Mental Gene-Editing for Investing in Volatile, Unproven, and Non-Linear Businesses
What’s Inside …
Business model overview
Value proposition, certifications, and operational strengths
Financial performance, margins, and growth targets
Evolution of company narrative: early 2025 vs late 2025
Operational issues: from one-off glitches to structural changes
Guidance and tone: ambition to reluctant silence
Fragility, black swans, and hidden risks
Forced shift toward antifragility: resilience and optionality
Analogy: from engine trouble to navigating a storm
IPO fads and busted expectations
Plummeting stock prices as margin-of-safety opportunities
The Lindy Effect and new IPOs: wait-and-watch heuristic
Recommended approaches
Long-term conviction, patience, and investment horizon
Spinoffs as an exception: proven longevity matters
Valuation under extreme uncertainty: randomness, lumpiness, higher failure probability, unpredictable cash flows
Upcoming case studies: valuing randomness and extreme uncertainty
Final insights: mental “gene-editing” from fearing volatility to seizing opportunity


